The U.S. Food and Drug Administration (FDA) has approved the Sapien 3, Sapien 3 Ultra and Sapien 3 Ultra Resilia TAVR valves from Edwards Lifesciences to treat patients with asymptomatic severe aortic ...

A randomized controlled trial using a digital health technology (DHT)-enabled intervention is feasible, with high patient retention, engagement and satisfaction, according to the mTECH Afib pilot ...

Varenicline, combined with behavioral counseling, is well tolerated and increases vaping cessation compared with placebo in youth who vape nicotine, do not regularly smoke tobacco and want to reduce ...

With accelerating urbanization in low- and middle-income countries contributing to significant environmental and societal impacts on cardiovascular health, a State of the Art Review published April 22 ...

Patients with adult congenital heart disease (ACHD) have worse outcomes in cardiac intensive care units (CICUs), particularly a high rate of readmissions and mortality, according to a new study ...

The ACC has launched an open comment period for the CathPCI Registry Risk Standardized Bleeding Model. Before completing the 10-minute survey, be sure to review the methodology document. The survey ...

The ACC and Heart Rhythm Society (HRS) have released a new Scientific Statement on guiding principles and best practices for effective same-day discharge (SDD) for patients undergoing intracardiac ...

The ACC's Guideline Clinical App is the mobile home of clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. The App brings the guidelines closer to the ...

The framework for the training of current and future generations in cardiovascular disease prevention is crucial. More interest and dedicated training in cardiovascular disease prevention can ...

An increasing number of academic faculty are engaging in innovation-related activities in technology, medical devices and health care delivery. In response to this growth, academic medical centers ...

Heart failure (HF) is the leading cause of morbidity and mortality for patients with adult congenital heart disease (ACHD), and there is a growing number of ACHD HF patients with medical, anatomic and ...

We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...